Silymarin ameliorates diet-induced gallstone formation by regulating gut microbiota-derived GCDCA to suppress ferroptosis-ROS-NFκB signaling pathway
Lists
Only you see this
Abstract
Gallstones (GS), a globally prevalent gastrointestinal disorder in adults, arise from multifactorial pathogenesis with dietary patterns serving as a key contributor. This study aimed to elucidate the therapeutic efficacy of silymarin in a diet-induced gallstone murine model established via lithogenic diet (LD) induction. LD-fed mice exhibited marked hepatic oxidative stress, inflammatory activation, and ferroptosis, accompanied by elevated serum glycochenodeoxycholic acid (GCDCA) levels. Our findings demonstrate that GCDCA triggers dose-dependent ferroptosis in murine hepatocytes, a process reversible by the ferroptosis inhibitor ferrostatin-1 (Fer-1). Mechanistically, GCDCA promotes hepatocyte ferroptosis through SQSTM1-KEAP1-NRF2 axis-mediated suppression of SLC7A11, while simultaneously activating NFκB signaling via ROS generation to inhibit FXR activity. Oral silymarin administration in gallstone-bearing mice exhibited dose-dependent therapeutic effects, with higher doses demonstrating optimal efficacy in: (1) reducing gallstone formation, (2) ameliorating hepatic histopathological damage and lipid accumulation, (3) suppressing hepatocyte ferroptosis, (4) decreasing hepatic inflammatory cytokines, and (5) normalizing serum ALT/AST levels. Further analysis revealed silymarin's ability to restore gut microbiota homeostasis, reduce serum GCDCA concentrations, and inhibit both ferroptosis and NFκB signaling through microbiota-dependent mechanisms. Collectively, silymarin exerts anti-gallstone effects by stabilizing gut microbiota to reduce serum GCDCA, inhibit hepatocyte ferroptosis and ROS-NFκB activation, and restore FXR expression and transcriptional activity. This study provides novel mechanistic insights and proposes microbiota-targeted therapeutic strategies for gallstone management.
BibTeX
@inproceedings{wang2025silymarin,
author = {Qiang Wang and Chenglong Han and Yi Zheng and Xuxu Liu and Zhenyi Lv and Zhiwei Du and Tianming Liu and Chenjun Hao and Xianzhi Meng and Tao Li and Dongbo Xue},
title = {{Silymarin ameliorates diet-induced gallstone formation by regulating gut microbiota-derived GCDCA to suppress ferroptosis-ROS-NFκB signaling pathway}},
booktitle = {Free},
year = {2025},
doi = {10.1016/j.freeradbiomed.2025.08.003},
}Loading related content...